Logo-aim
Arch Iran Med. 2021;24(1): 1-6. doi: 10.34172/aim.2021.01

Original Article

Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013

Fatemeh Salamat 1 ORCID, Ali Aryannia 1, Siamak Rajaei 1, Mohammad Naeimi-Tabiei 1, Reza Afghani 1, Seyyed Mehdi Sedaghat 2, Esmaeil Naeimi-Tabiei 3, Faezeh Salamat 4, Reza Hosseinpour 2, Abdolreza Fazel 4 * ORCID, Marzieh Araghi 5, Gholamreza Roshandel 6,4

Cited by CrossRef: 5

1- Ghalandari M, Sheikhzade S, Zardosht K, Sadeghi G, Taheri Soodejani M. Spatial and temporal analysis of thyroid cancer incidence in Guilan Province, Northern Iran, 2009–2018. Cancer Epidemiology. 2024;90:102579 [Crossref]
2- Taziki M, Rajaei S, Firouzei G, Hashemzadeh F, Rajabalian M, Mansoury M, Sedaghat S, Ghahraman F, Ghasemi-Kebria F, Weiderpass E, Roshandel G. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran. Cancer Epidemiology. 2022;80:102247 [Crossref]
3- Wang Y, Wang W, Li P, Qi X, Hu W. Risk Analysis of Thyroid Cancer in China: A Spatial Analysis. Geographies. 2022;2(4):577 [Crossref]
4- Nabahati M, Moazezi Z. Performance of European Thyroid Imaging Reporting and Data System in Stratifying Malignancy Risk of Thyroid Nodules: A Prospective Study. 2023;31(2):127 [Crossref]
5- Gharib M, Afghani R, Rajaei S, Roshandel G, Alijani A, Karamollahi Z, Tatari M, Mohajernoei S, Hosseini S, Rezazadeh S. Clinical Implication of the New AI-TIRADS Classification of Thyroid Nodules; Our Real Clinical Experience. Shiraz E-Med J. 2024;25(11) [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.